论文部分内容阅读
目的:探析慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭采用支气管肺泡灌洗(BAL)联合无创正压通气(NIPPV)治疗的临床价值。方法:选取本院COPD合并Ⅱ型呼吸衰竭患者94例,分为对照组和观察组,对照组仅采用NIPPV治疗,观察组采用BAL联合NIPPV治疗,对比分析两组患者的平均动脉压、心率和APACHEⅡ评分。结果:两组患者在平均动脉压、心率方面差异不大,差异无统计学意义(P>0.05)。两组患者治疗前相比与APACHEⅡ评分明显下降,差异有统计学意义(P<0.05),观察组APACHEⅡ评分显著低于对照组,差异具有统计学意义(P<0.05)。结论:COPD合并Ⅱ型呼吸衰竭采用BAL联合NIPPV治疗能够有效降低患者的APACHEⅡ评分,起到更好的治疗效果,具有较高的临床应用价值。
Objective: To investigate the clinical value of bronchoalveolar lavage (BAL) combined with noninvasive positive pressure ventilation (NIPPV) in patients with chronic obstructive pulmonary disease (COPD) and type Ⅱ respiratory failure. Methods: A total of 94 COPD patients with type Ⅱ respiratory failure were selected and divided into control group and observation group. The control group was treated with NIPPV only. The observation group was treated with BAL combined with NIPPV. The mean arterial pressure and heart rate APACHE Ⅱ score. Results: There was no significant difference in mean arterial pressure and heart rate between the two groups, with no significant difference (P> 0.05). Compared with APACHE Ⅱ score before treatment, APACHE Ⅱ score decreased significantly in both groups (P <0.05). The APACHE Ⅱ score in the observation group was significantly lower than that in the control group (P <0.05). Conclusions: BAL combined with NIPPV can effectively reduce APACHEⅡscore in patients with COPD and type Ⅱ respiratory failure, which has better therapeutic effect and higher clinical value.